[MO40] Mini-Oral Session 40　Lung Cancer / Thoracic Cancer 6（Biomarker）
【E】

[MO40-1] TTF-1 in non-Sq NSCLC is associated with the efficacy of PD-1/PD-L1 inhibitors combined with Pemetrexed plus platinum

^○Ritsu Ibusuki¹, Yasuto Yoneshima¹, Norikazu Matsuo², Taishi Harada³, Yuko Tsuchiya⁴, Mikiko Hashisako⁵, Junji Kishimoto⁶, Aiko Sakamoto¹, Takayuki Nakanishi¹, Maako Ide¹, Hirono Tsutsumi¹, Koji Okamura¹, Keiichi Ota¹, Eiji Iwama¹, Kentaro Tanaka¹, Yoshinao Oda⁵, Isamu Okamoto¹ (1.Research Institute for Diseases of the Chest, Graduate School of Medical Sciences, Kyushu University, 2.Division of Respirology, Neurology, and Rheumatology, Department of Internal Medicine, Kurume University School of Medicine, 3.Department of Respiratory Medicine, Japan Community Health Care Organization (JCHO) Kyushu Hospital, 4.Department of Respiratory Medicine, Kitakyushu Municipal Medical Center, 5.Department of Anatomic Pathology, Graduate School of Medical Sciences, 6.Department of Research and Development of Next Generation Medicine, Kyushu University Hospital)